Use of hypertonic saline solutions in treatment of cerebral edema and intracranial hypertension
about
Efficiency of 7.2% hypertonic saline hydroxyethyl starch 200/0.5 versus mannitol 15% in the treatment of increased intracranial pressure in neurosurgical patients - a randomized clinical trial [ISRCTN62699180]Aquaporin-4 and Cerebrovascular DiseasesUpdate on the 2012 guidelines for the management of pediatric traumatic brain injury - information for the anesthesiologistMethylophiopogonanone A Protects against Cerebral Ischemia/Reperfusion Injury and Attenuates Blood-Brain Barrier Disruption In VitroManagement of raised intracranial pressure in children with traumatic brain injuryPediatric head injury: a pain for the emergency physician?Novel treatment targets for cerebral edemaIn vivo photoacoustic tomography of mouse cerebral edema induced by cold injury.Extreme hypernatremia as a probable cause of fatal arrhythmia: a case report.Dural venous sinuses distortion and compression with supratentorial mass lesions: a mechanism for refractory intracranial hypertension?Advances in spontaneous intracerebral haemorrhage.The management of diabetic ketoacidosis in childrenEfficacy and Safety of Continuous Micro-Pump Infusion of 3% Hypertonic Saline combined with Furosemide to Control Elevated Intracranial Pressure.Hypertonic saline alleviates experimentally induced cerebral oedema through suppression of vascular endothelial growth factor and its receptor VEGFR2 expression in astrocytes.Considerations in fluids and electrolytes after traumatic brain injury.Hyperglycemic crises and their complications in children.Clinical review: Critical care management of spontaneous intracerebral hemorrhage.Hypertonic saline attenuates cord swelling and edema in experimental spinal cord injury: a study utilizing magnetic resonance imaging.Evaluation of the Maintained Effect of 3% Hypertonic Saline Solution in an Animal Model of Intracranial HypertensionEffects of hypertonic (7%) saline on brain injury in experimental Escherichia coli meningitis.New concepts in treatment of pediatric traumatic brain injury.Intensive care management of acute stroke: general management.Induced and sustained hypernatremia for the prevention and treatment of cerebral edema following brain injury.Safety and efficacy of repeated doses of 14.6 or 23.4 % hypertonic saline for refractory intracranial hypertension.Hypernatremia in patients with severe traumatic brain injury: a systematic review.Hematoma Enlargement Among Patients with Traumatic Brain Injury: Analysis of a Prospective Multicenter Clinical Trial.Dexmedetomidine for Refractory Intracranial Hypertension.Osmotherapy With Hypertonic Saline Attenuates Global Cerebral Edema Following Experimental Cardiac Arrest via Perivascular Pool of Aquaporin-4Refractory hypokalemia during barbiturate coma therapy used for treating refractory intracranial hypertension in traumatic brain injury.Repeated dosing of 23.4% hypertonic saline for refractory intracranial hypertension. A case report.Effect of hypertonic saline on hypotension following induction of general anesthesia: A randomized controlled trial.Protective effects of alpha-tocopherol and mannitol in both circulatory shock and cerebral ischaemia injury in rat heatstroke.Use of hypertonic saline in the treatment of cerebral edema in diabetic ketoacidosis (DKA).Predictable reduction of intracranial hypertension with hypertonic saline hydroxyethyl starch: a prospective clinical trial in critically ill patients with subarachnoid haemorrhage.Hypertonic saline more efficacious than mannitol in lethal intracranial hypertension model.Effect of duration of osmotherapy on blood-brain barrier disruption and regional cerebral edema after experimental stroke.Plasma arginine-vasopressin following experimental stroke: effect of osmotherapy.A comparison of equivolume, equiosmolar solutions of hypertonic saline and mannitol for brain relaxation during elective supratentorial craniotomy.Real-time Noninvasive Monitoring of Intracranial Fluid Shifts During Dialysis Using Volumetric Integral Phase-Shift Spectroscopy (VIPS): A Proof-of-Concept Study.Hypertonic saline and its effect on intracranial pressure, cerebral perfusion pressure, and brain tissue oxygen.
P2860
Q24813241-FD602D69-E5AA-4B42-AD75-CEEE85188819Q26741216-FEA3476C-9ABE-4679-8D29-532C06006E54Q26998554-CE8000D5-C403-40F2-A172-DBAA59B0AE03Q27309034-5789FB02-EDE5-408E-88C6-F8CA3435DE2BQ28081998-8A7F603E-E6AE-4087-B9A1-89BB53194625Q28083220-461B5578-E789-40FF-9DD5-D73E31546851Q28254203-9B011984-4925-4054-AC09-E99E036EA448Q30467110-D5FE570C-ED9A-4DE2-9E77-AEA97DA17108Q31135518-B55C0FF9-04C0-4F16-BCAE-F4192D50340FQ33735176-25DE20A8-2DCF-4EA0-BC3D-213FC0DB9971Q34274601-AB61058A-313E-4D00-88C0-3B9A63202597Q35111547-B29E596B-6161-4C2A-839D-46C259F70926Q35794303-BA1E6B56-E306-466C-BFCE-0DB682EB21E8Q36161763-423BCBDA-050F-4C66-A594-A861E3481F56Q36602392-DC480A2F-9856-4DA9-90BB-0666E0C83682Q36742226-1DC6BD7D-AC1D-4BA6-80CC-519B7BA2DBEFQ37106076-AC9E1584-39D9-4A99-A862-6F90C45050C7Q37359201-3DAEDB6A-97E2-40DB-9C04-2767F2D6F40AQ37372118-E16930E0-3851-4EE4-A3A6-D725CE72478CQ37425727-005979AB-9A73-4533-8234-DC43CD84C89BQ37585771-330C38E7-8016-4B3F-98D3-2636F14D72BCQ37599918-F006A3CB-709C-42D1-A5DF-097D99C703ECQ38087280-861F3EC9-57DB-4EC2-A920-5CEDC6A20E0CQ38136540-0E05B04E-B9C8-4CF3-8ED2-511F11FB5A0EQ38160310-0640DAD1-0BE5-400D-80F6-4C04E00008CCQ38971542-164416EE-DFF2-4FF3-B26E-1F71ADE0C2D6Q38999296-47B85E5E-B724-40E5-85B6-0DDC3D1B6A4AQ41766316-4DFCDB22-E388-4C66-851A-EF7055788212Q41862699-E8237574-22DB-4785-9060-A530E2383482Q42560298-545ADB6E-2B64-433D-9D22-44E3CC35944AQ42882456-D13AC0BE-7A20-4A2B-9DBD-C3675C1A6558Q44600830-9FDF477F-9678-4DAB-9357-81C478FC71B0Q44796622-A055B9F3-B9DC-4562-A38B-C0BE94AD5D22Q45048402-114B6FD5-AFF8-444A-9087-BABCACA43309Q46077179-8870738A-9F50-4478-8457-601C7AF4C013Q46819230-C42E729A-FE19-4390-B9C1-49942251A328Q46843893-814D1AD3-89FC-43A4-9039-F81A273484BAQ47627401-911B3E9F-0862-4E04-918B-F1CE6D60B9D9Q47712801-68EFA5C8-E0ED-4EBE-81E1-264623D41EE2Q48400088-DBB2450D-B497-422A-9A12-B566CA568EE3
P2860
Use of hypertonic saline solutions in treatment of cerebral edema and intracranial hypertension
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Use of hypertonic saline solut ...... and intracranial hypertension
@ast
Use of hypertonic saline solut ...... and intracranial hypertension
@en
Use of hypertonic saline solut ...... and intracranial hypertension
@nl
type
label
Use of hypertonic saline solut ...... and intracranial hypertension
@ast
Use of hypertonic saline solut ...... and intracranial hypertension
@en
Use of hypertonic saline solut ...... and intracranial hypertension
@nl
prefLabel
Use of hypertonic saline solut ...... and intracranial hypertension
@ast
Use of hypertonic saline solut ...... and intracranial hypertension
@en
Use of hypertonic saline solut ...... and intracranial hypertension
@nl
P3181
P1476
Use of hypertonic saline solut ...... and intracranial hypertension
@en
P2093
A I Qureshi
J I Suarez
P304
P3181
P356
10.1097/00003246-200009000-00032
P407
P577
2000-09-01T00:00:00Z